Brooklands Fund Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.84M Sell
21,102
-5
-0% -$1.85K 6.91% 3
2026
Q1
$6.2M Buy
21,107
+21,105
+1,055,250% +$6.94M 6.97% 3
2025
Q4
$15.2K Buy
+2
New +$676 0.01% 76

Other funds holding ELV

Brooklands Fund Management's ELV Position: Q2 2026 in Review

Brooklands Fund Management reduced its Elevance Health (ELV) stake by 0.02% in Q2 2026, selling an estimated $1.85K and leaving 21,102 shares worth $8.84M. The position accounts for 6.91% of the portfolio, ranked #3.

Brooklands Fund Management first reported a position in ELV in Q4 2025 and has held it in 3 quarters since. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Brooklands Fund Management held 21,102 shares of Elevance Health worth $8.84M as of Q2 2026.
  • Brooklands Fund Management sold 5 Elevance Health shares in Q2 2026, an estimated $1.85K.
  • Elevance Health made up 6.91% of Brooklands Fund Management's portfolio in Q2 2026, its #3 holding.
  • Brooklands Fund Management first reported a position in Elevance Health in Q4 2025 and has held it in 3 quarters since.
  • 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Brooklands Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.